Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Balch

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
Surgery|August 1, 1985
Cellular immune defects in patients with melanoma involving interleukin-2-activated lymphocyte cytotoxicity and a serum suppressor factorC M Balch, K Itoh, A B Tilden
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Lysis of human solid tumor cells by lymphokine-activated natural killer cellsK Itoh, A B Tilden, C M Balch
The New England Journal of Medicine|January 30, 1992
Cutaneous melanomaO Eton, S S Legha, C M Balch
The Journal of Experimental Medicine|October 1, 1988
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptorK Itoh, C D Platsoucas, C M Balch
Annals of Surgery|August 1, 1983
The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatmentsC M Balch, J R Durant, A A Bartolucci
Annals of Surgery|February 1, 1983
Abdominal wound closure. A randomized prospective study of 571 patients comparing continuous vs. interrupted suture techniquesP C Richards, C M Balch, J S Aldrete
American Journal of Surgery|February 1, 1983
Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patientsC M Balch, M M Urist, M L McGregor
Southern Medical Journal|December 1, 1993
Think melanomaC J Cockerell, J B Howell, C M Balch
Advances in Experimental Medicine and Biology|January 1, 1979
Partial immunochemical characterization of human B-lymphocyte differentiation antigen (BDA-1)E W Ades, P A Dougherty, C M Balch
Annals of Surgery|March 1, 1993
Clinical decision-making in early breast cancerC M Balch, S E Singletary, K I Bland
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Surgery|August 1, 1985
Cellular immune defects in patients with melanoma involving interleukin-2-activated lymphocyte cytotoxicity and a serum suppressor factorC M Balch, K Itoh, A B Tilden
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Lysis of human solid tumor cells by lymphokine-activated natural killer cellsK Itoh, A B Tilden, C M Balch
The New England Journal of Medicine|January 30, 1992
Cutaneous melanomaO Eton, S S Legha, C M Balch
The Journal of Experimental Medicine|October 1, 1988
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptorK Itoh, C D Platsoucas, C M Balch
Annals of Surgery|August 1, 1983
The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatmentsC M Balch, J R Durant, A A Bartolucci
Annals of Surgery|February 1, 1983
Abdominal wound closure. A randomized prospective study of 571 patients comparing continuous vs. interrupted suture techniquesP C Richards, C M Balch, J S Aldrete
American Journal of Surgery|February 1, 1983
Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patientsC M Balch, M M Urist, M L McGregor
Southern Medical Journal|December 1, 1993
Think melanomaC J Cockerell, J B Howell, C M Balch
Advances in Experimental Medicine and Biology|January 1, 1979
Partial immunochemical characterization of human B-lymphocyte differentiation antigen (BDA-1)E W Ades, P A Dougherty, C M Balch
Annals of Surgery|March 1, 1993
Clinical decision-making in early breast cancerC M Balch, S E Singletary, K I Bland
Pageof 23